Anne Voss
Impact in
- Rheumatology top 0.5%
- Systemic Lupus Erythematosus Research
- Immunology top 2%
- T-cell and B-cell Immunology
- Atherosclerosis and Cardiovascular Diseases
- Complement system in diseases
Papers in
- Rheumatology 46
- Systemic Lupus Erythematosus Research 43
- Immunology 33
- Atherosclerosis and Cardiovascular Diseases 15
- T-cell and B-cell Immunology 12
- Complement system in diseases 4
- Co-authors
- Howard SprecherShankar K. SankarappaPeter JunkerHelle LaustrupSøren JacobsenPeter GarredUlrik TarpSøren Thue Lillevang
- Journals
- Lupus (10 papers)Lupus Science & Medicine (4 papers)Scandinavian Journal of Rheumatology (4 papers)The Journal of Rheumatology (4 papers)Annals of the Rheumatic Diseases (4 papers)
- Partner nations
- DenmarkUnited StatesSweden
In The Last Decade
Anne Voss
81 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Rheumatology 1.0k
- Immunology 1.0k
- Biochemistry 234
- Nutrition and Dietetics 361
- Nephrology 120
Countries citing papers authored by Anne Voss
This map shows the geographic impact of Anne Voss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Voss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Voss more than expected).
Fields of papers citing papers by Anne Voss
This network shows the impact of papers produced by Anne Voss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Voss. The network helps show where Anne Voss may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anne Voss, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 5 | |
| 5 | 2022 | 2 | |
| 6 | The impact of COVID-19 on population-level drug utilization of alendronate | 2021 | 1 |
| 7 | 2021 | 13 | |
| 8 | 2020 | 1 | |
| 9 | 2019 | 22 | |
| 10 | 2019 | 11 | |
| 11 | 2019 | 19 | |
| 12 | 2018 | 40 | |
| 13 | 2015 | 20 | |
| 14 | 2013 | 17 | |
| 15 | 2013 | 187 | |
| 16 | 2011 | 35 | |
| 17 | 2008 | 106 | |
| 18 | Effect of a Protein and Energy Dense N-3 Fatty Acid Enriched Oral Supplement on Loss of Weight and Lean Tissue in Cancer Cachexia: A Randomised Double Blind Trial | 2003 | 5 |
| 19 | 1998 | 16 | |
| 20 | 1987 | 2 |
About Anne Voss
Anne Voss is a scholar working on Rheumatology, Immunology, Leadership and Management, Hematology and Radiology, Nuclear Medicine and Imaging, having authored 85 papers that have together received 2.4k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (43 papers), Atherosclerosis and Cardiovascular Diseases (15 papers), Monoclonal and Polyclonal Antibodies Research (13 papers), T-cell and B-cell Immunology (12 papers), Systemic Sclerosis and Related Diseases (7 papers), Vasculitis and related conditions (5 papers), Complement system in diseases (4 papers) and Platelet Disorders and Treatments (4 papers). The work is most often cited by research in Rheumatology (1.0k citations), Immunology (1.0k citations), Biochemistry (234 citations), Nutrition and Dietetics (361 citations) and Nephrology (120 citations). Anne Voss has collaborated with scholars based in Denmark, United States and Sweden. Frequent co-authors include Howard Sprecher, Shankar K. Sankarappa, Peter Junker, Helle Laustrup, Søren Jacobsen, Peter Garred, Ulrik Tarp, Søren Thue Lillevang, Anders Bengtsson and Christoffer Tandrup Nielsen. Their work appears in journals such as Lupus, Lupus Science & Medicine, Scandinavian Journal of Rheumatology, The Journal of Rheumatology and Annals of the Rheumatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.